4.1 Article

Efficacy and Safety According to the Dose of Valganciclovir for Cytomegalovirus Prophylaxis in Transplantation: Network Meta-analysis Using Recent Data

Related references

Note: Only part of the references are listed.
Article Immunology

Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation

Aurora Paez-Vega et al.

Summary: This study focused on CMV-seropositive kidney transplant recipients, with over half of patients recovering or maintaining CMV-CMI within the first month post-transplantation. Pretransplant IFN-γ level showed a strong association with the recovery kinetics, while the ATG dose was not associated with CMV-CMI.

JOURNAL OF INFECTIOUS DISEASES (2021)

Review Immunology

T cell responses to cytomegalovirus

Paul Klenerman et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Health Care Sciences & Services

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

Georgia Salanti et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Immunology

Influence of Cytomegalovirus Disease in Outcome of Solid Organ Transplant Patients

L. Linares et al.

TRANSPLANTATION PROCEEDINGS (2011)

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Mathematical & Computational Biology

Checking consistency in mixed treatment comparison meta-analysis

S. Dias et al.

STATISTICS IN MEDICINE (2010)

Article Mathematical & Computational Biology

Combination of direct and indirect evidence in mixed treatment comparisons

G Lu et al.

STATISTICS IN MEDICINE (2004)

Article Medicine, General & Internal

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

DF Martin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)